» Authors » Takahiro Takazono

Takahiro Takazono

Explore the profile of Takahiro Takazono including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 181
Citations 993
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Ishimoto H, Sakamoto N, Yura H, Takazono T, Kido T, Matsumoto K, et al.
Respir Investig . 2025 Jan; 63(1):180-182. PMID: 39754899
Sargramostim, a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation therapy, was recently approved for pharmaceutical use in Japan and shows promise as a treatment for autoimmune pulmonary alveolar proteinosis (APAP)....
12.
Torigoe K, Yoshidome A, Ashizawa K, Fukuda H, Otsuka E, Tsuji K, et al.
Cureus . 2024 Dec; 16(11):e74856. PMID: 39737278
A 63-year-old woman undergoing peritoneal dialysis (PD) presented to our hospital with abdominal pain, diarrhea, and cloudy PD effluent. An elevated white blood cell count in the PD effluent led...
13.
Takazono T, Saito Y, Tashiro M, Yoshida M, Takeda K, Ide S, et al.
Infect Dis Ther . 2024 Dec; 14(1):245-259. PMID: 39722117
Introduction: Despite the ongoing efforts to refine treatment durations and methods for patients with chronic pulmonary aspergillosis, the clinical use of antifungal agents remains unclear. This study aimed to describe...
14.
Torigoe K, Yoshidome A, Otsuka E, Tsuji K, Yamashita A, Kitamura M, et al.
Cureus . 2024 Dec; 16(11):e74294. PMID: 39717310
A 46-year-old woman on peritoneal dialysis (PD) had cloudy peritoneal dialysis effluent that had persisted for 10 days by the time she visited our hospital. The white blood cell count...
15.
Hirayama T, Miyazaki T, Tanaka R, Kitahori N, Yoshida M, Takeda K, et al.
Antimicrob Agents Chemother . 2024 Dec; 69(2):e0150824. PMID: 39692503
is an emerging pathogenic fungus that is highly resistant to existing antifungal drugs. Manogepix is a novel antifungal agent that exerts antifungal activity by inhibiting glycosylphosphatidylinositol anchor biosynthesis. Although the...
16.
Moriishi M, Takazono T, Hashizume J, Aibara N, Kutsuna Y, Okamoto M, et al.
Clin Biochem . 2024 Dec; 135():110865. PMID: 39689808
Background: The factors contributing to the development of severe coronavirus disease 2019 (COVID-19) following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain unclear. Although the presence of immune...
17.
Tashiro M, Takazono T, Izumikawa K
Med Mycol J . 2024 Dec; 65(4):99-102. PMID: 39617462
Fungi are categorized into Risk or Hazard Groups, depending on their potential to harm humans, with groupings ranging from 1 (least risky) to 4 (most risky). Similarly, Biosafety or Containment...
18.
Sengupta A, Ray A, Upadhyay A, Izumikawa K, Tashiro M, Kimura Y, et al.
Lancet Infect Dis . 2024 Dec; 25(3):312-324. PMID: 39617023
Background: Despite antifungal treatment, chronic pulmonary aspergillosis (CPA) is associated with substantial morbidity and mortality. We conducted a systematic review and meta-analysis to evaluate rates of mortality and its predictors...
19.
Setoguchi D, Iwanaga N, Ito Y, Hirayama T, Yoshida M, Takeda K, et al.
Mycoses . 2024 Oct; 67(10):e13804. PMID: 39438422
Exophiala dermatitidis is an emerging black fungus that causes pulmonary infections that may be underestimated by conventional culture methods. We encountered one case that initially appeared to be yeast and...
20.
Katsuoka S, Itonaga H, Sawayama Y, Chiwata M, Watanabe H, Yamada Y, et al.
Leuk Res Rep . 2024 Oct; 22:100483. PMID: 39403234
A 63-year-old male received a third allogeneic hematopoietic stem cell transplantation with voriconazole prophylaxis for relapsed acute myeloid leukemia. He developed septic arthritis without any typical skin lesions due to...